These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
549 related articles for article (PubMed ID: 20370594)
1. Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation. Su ZX; Shi YN; Teng LS; Li X; Wang LX; Meng QF; Teng LR; Li YX Pharm Dev Technol; 2011 Aug; 16(4):377-84. PubMed ID: 20370594 [TBL] [Abstract][Full Text] [Related]
2. Microsphere delivery of Risperidone as an alternative to combination therapy. D'Souza S; Faraj J; DeLuca P Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159 [TBL] [Abstract][Full Text] [Related]
3. Sustained release of risperidone from biodegradable microspheres prepared by in-situ suspension-evaporation process. An T; Choi J; Kim A; Lee JH; Nam Y; Park J; Sun Bk; Suh H; Kim CJ; Hwang SJ Int J Pharm; 2016 Apr; 503(1-2):8-15. PubMed ID: 26899975 [TBL] [Abstract][Full Text] [Related]
4. Effect of bases with different solubility on the release behavior of risperidone loaded PLGA microspheres. Hu Z; Liu Y; Yuan W; Wu F; Su J; Jin T Colloids Surf B Biointerfaces; 2011 Aug; 86(1):206-11. PubMed ID: 21524893 [TBL] [Abstract][Full Text] [Related]
5. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere. Su Z; Sun F; Shi Y; Jiang C; Meng Q; Teng L; Li Y Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1251-6. PubMed ID: 19881277 [TBL] [Abstract][Full Text] [Related]
6. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization. Xu H; Zhong H; Liu M; Xu C; Gao Y Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119 [TBL] [Abstract][Full Text] [Related]
7. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres. Janoria KG; Mitra AK Int J Pharm; 2007 Jun; 338(1-2):133-41. PubMed ID: 17363204 [TBL] [Abstract][Full Text] [Related]
8. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis. Duvvuri S; Janoria KG; Pal D; Mitra AK J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010 [TBL] [Abstract][Full Text] [Related]
9. Preparation of ONO-1301-loaded poly(lactide-co-glycolide) microspheres and their effect on nerve conduction velocity. Hazekawa M; Sakai Y; Yoshida M; Haraguchi T; Morisaki T; Uchida T J Pharm Pharmacol; 2011 Mar; 63(3):362-8. PubMed ID: 21749383 [TBL] [Abstract][Full Text] [Related]
10. Development of near zero-order release PLGA-based microspheres of a novel antipsychotic. Zhao J; Wang L; Fan C; Yu K; Liu X; Zhao X; Wang D; Liu W; Su Z; Sun F; Li Y Int J Pharm; 2017 Jan; 516(1-2):32-38. PubMed ID: 27825865 [TBL] [Abstract][Full Text] [Related]
11. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method. Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287 [TBL] [Abstract][Full Text] [Related]
12. Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters. Chaisri W; Ghassemi AH; Hennink WE; Okonogi S Colloids Surf B Biointerfaces; 2011 Jun; 84(2):508-14. PubMed ID: 21353499 [TBL] [Abstract][Full Text] [Related]
13. Formulation and in vitro/in vivo evaluation of terbutaline sulphate incorporated in PLGA (25/75) and L-PLA microspheres. Selek H; Sahin S; Ercan MT; Sargon M; Hincal AA; Kas HS J Microencapsul; 2003; 20(2):261-71. PubMed ID: 12554379 [TBL] [Abstract][Full Text] [Related]
14. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir. Duvvuri S; Janoria KG; Mitra AK J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919 [TBL] [Abstract][Full Text] [Related]
15. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method. Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954 [TBL] [Abstract][Full Text] [Related]
16. Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(D,L-lactide-co-glycolide) blend microspheres fabricated by spray drying. Wang L; Chaw CS; Yang YY; Moochhala SM; Zhao B; Ng S; Heller J Biomaterials; 2004 Jul; 25(16):3275-82. PubMed ID: 14980422 [TBL] [Abstract][Full Text] [Related]
17. Effects of formulation parameters on encapsulation efficiency and release behavior of thienorphine loaded PLGA microspheres. Yang Y; Gao Y; Mei X Pharm Dev Technol; 2013; 18(5):1169-74. PubMed ID: 21967467 [TBL] [Abstract][Full Text] [Related]
18. Preparation and characteristics of interferon-alpha poly(lactic-co-glycolic acid) microspheres. Yang F; Song FL; Pan YF; Wang ZY; Yang YQ; Zhao YM; Liang SZ; Zhang YM J Microencapsul; 2010; 27(2):133-41. PubMed ID: 20121486 [TBL] [Abstract][Full Text] [Related]
19. Validation of USP apparatus 4 method for microsphere in vitro release testing using Risperdal Consta. Rawat A; Stippler E; Shah VP; Burgess DJ Int J Pharm; 2011 Nov; 420(2):198-205. PubMed ID: 21889583 [TBL] [Abstract][Full Text] [Related]
20. β-methasone-containing biodegradable poly(lactide-co-glycolide) acid microspheres for intraarticular injection: effect of formulation parameters on characteristics and in vitro release. Song X; Song SK; Zhao P; Wei LM; Jiao HS Pharm Dev Technol; 2013; 18(5):1220-9. PubMed ID: 22295954 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]